LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Drug Safety Update › 24 Oct 2024
Drug Safety Update

Bromocriptine

Published on 24 Oct 2024 · source: MHRA — Medicines and Healthcare products Regulatory Agency
A safety review has been conducted by the MHRA following a Yellow Card report concerning a patient who was taking bromocriptine. The review concluded that blood pressure monitoring of patients prescri…
Drug Safety Update on GOV.UK ↗ All events: Bromocriptine

What this means

Drug Safety Update is the MHRA bulletin for healthcare professionals: new safety information, restrictions of use and recommendations for monitoring.

Summary

A safety review has been conducted by the MHRA following a Yellow Card report concerning a patient who was taking bromocriptine. The review concluded that blood pressure monitoring of patients prescribed with this drug is essential especially during the first days of treatment.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.